ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
허혈성 괴사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년의 연간 평균 성장률(CAGR)은 9.3%로 성장할 전망이며, 12억 7,000만 달러로 성장이 예측됩니다. 예측기간 동안 예상되는 성장은 코르티코스테로이드 유발성 골괴사 발생률 증가, 인공슬관절 치환술 및 고관절 수술 건수 증가, 약제 승인 급증, 교통사고율 증가, 뼈손상 유병률 증가 등에 기인하고 있습니다. 예측 기간 동안 예상되는 주요 동향에는 기술 혁신, 영상 기술 진보, AI 주도 진단 솔루션, 3D 프린팅 외과용 임플란트, 재생 성형 생물 공학, 세포 요법 등이 포함됩니다.
인공 슬관절 치환술과 인공 고관절 치환술 증가는 향후 수년간 허혈성 괴사 시장의 성장을 가속할 것으로 예측됩니다. 인공 슬관절 치환술이나 인공 고관절 치환술은 손상된 관절을 치환하여 중증 혈관 괴사의 통증을 완화하는 것을 목적으로 한 외과 수술입니다. 이러한 외과 수술의 증가는 변형성 관절증의 이환율 증가에 기인합니다. 퇴행성 관절염은 심한 관절통과 운동기능 저하를 일으키는 질환으로 삶의 질을 높이기 위해 외과적 개입이 필요한 경우가 많습니다. 허혈성 괴사는 혈류 감소로 인한 뼈 조직의 사멸을 야기하고 관절의 붕괴나 악화를 자주 일으키기 때문에 이러한 수술의 필요성을 창출하는 데 중요한 역할을 하고 있습니다. 예를 들어 2023년 9월 미국에 거점을 둔 헬스케어 기술기업인 Curvo Labs, Inc.는 미국의 인공 슬관절 치환술 건수가 2021년 123만 5,835건에서 2022년 129만 9,084건으로 증가했다고 보고했습니다. 이처럼 인공 슬관절 치환술과 인공 고관절 치환술 건수의 증가가 혈관 괴사 시장의 성장을 촉진하고 있습니다.
헬스케어 지출 증가는 향후 허혈성 괴사 시장의 성장을 지원할 것으로 예측되고 있습니다. 헬스케어 지출이란 특정 인구 및 헬스케어 시스템에서 의료 서비스, 치료, 건강 관련 제품에 대한 총 지출을 말합니다. 이 지출은 지속적인 관리, 잦은 통원, 고액의 약제를 필요로 하는 만성 질환의 만연으로 인해 증가하고 있습니다. 혈관 괴사의 맥락에서 헬스케어 지출의 증가는 조기 진단, 선진적 치료 옵션, 외과적 개입에 대한 접근을 용이하게 하고 병세 관리 및 환자의 회귀 개선을 지원합니다. 예를 들면, 2025년 4월, 미국을 거점으로 하는 의사와 의료생을 대표하는 조직인 미국 의사회는, 미국의 의료비는 2022년의 4.6% 증가에서 2023년에는 7.5% 증가의 4조 9,000억 달러, 1인당 1만 4,570 달러가 되었다고 보고했습니다. 따라서 의료비의 증가가 허혈성 괴사 시장의 성장에 기여하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향 및 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁 및 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석 및 전략 분석 프레임워크
세계의 허혈성 괴사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인 및 억제요인)
최종 이용 산업의 분석
세계의 허혈성 괴사 시장 : 성장률 분석
세계의 허혈성 괴사 시장 실적 : 규모 및 성장(2019-2024년)
세계의 허혈성 괴사 시장 예측 : 규모 및 성장(2024-2029년, 2034년)
세계의 허혈성 괴사 : 전체 시장 규모(TAM)
제6장 시장 세분화
세계의 허혈성 괴사 시장 : 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
외상성 허혈성 괴사
비외상성 허혈성 괴사
세계의 허혈성 괴사 시장 : 진단별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
화상 진단
생검
컴퓨터 단층 촬영 스캔
양전자 방출 단층 촬영
X선
세계의 허혈성 괴사 시장 : 치료 유형별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
의약품
수술
물리치료
라이프 스타일의 변화
뼈 이식
세계의 허혈성 괴사 시장 : 최종 사용자별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
병원
전문 클리닉
재활센터
외래수술센터(ASC)
재택 케어
세계의 허혈성 괴사 시장 : 외상성 허혈성 괴사별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
골절유발성 허혈성 괴사
전위유발성 허혈성 괴사
수술 후 허혈성 괴사
압박 손상 관련 허혈성 괴사
스포츠 부상 관련 허혈성 괴사
세계의 허혈성 괴사 시장 : 비외상성 허혈성 괴사별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
스테로이드 유발성 허혈성 괴사
알코올 유발성 허혈성 괴사
겸상 적혈구증 관련 허혈성 괴사
루푸스 관련 허혈성 괴사
방사선요법 유발성 허혈성 괴사
특발성 허혈성 괴사
제7장 지역별 및 국가별 분석
세계의 허혈성 괴사 시장 : 지역별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
세계의 허혈성 괴사 시장 : 국가별 분석 및 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도 및 기업 프로파일
허혈성 괴사 시장 : 경쟁 구도
허혈성 괴사 시장 : 기업 프로파일
Stryker Corporation
Massachusetts General Hospital
Zimmer Biomet Holdings Inc.
Smith & Nephew plc
Stanford Health Care
제31장 기타 주요 기업 및 혁신 기업
Apollo Hospitals Enterprise Limited
Singapore General Hospital Pte Ltd.
Fortis Healthcare Limited
Narayana Hrudayalaya Limited
Bumrungrad International Hospital Co. Ltd.
Aster DM Healthcare Limited
Mount Elizabeth Hospital Pte Ltd.
Gleneagles Hospital Pte Ltd.
Shalby Limited
Texas Orthopedic Hospital LLC
Regrow Biosciences Pvt. Ltd.
Maxcure Hospitals Limited
Medicover Hospitals Private Limited
Mesoblast Limited
Athersys Inc.
제32장 세계 시장 경쟁 벤치마킹 및 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문 및 전략
허혈성 괴사 시장(2029년) : 새로운 기회를 제공하는 국가
허혈성 괴사 시장(2029년) : 새로운 기회를 제공하는 부문
허혈성 괴사 시장(2029년) : 성장전략
시장 동향에 의한 전략
경쟁 전략
제36장 부록
AJY
영문 목차
영문목차
Avascular necrosis (AVN) is a condition characterized by the death of bone tissue due to an insufficient blood supply. When blood flow to a bone is reduced or interrupted, bone cells begin to deteriorate, ultimately leading to the collapse of the bone structure and potential joint damage. The condition may arise from factors such as physical trauma, prolonged steroid use, excessive alcohol intake, or certain underlying medical conditions.
Avascular necrosis is primarily classified into trauma-related and non-trauma-related avascular necrosis. Trauma-related AVN develops following bone injuries like fractures or joint dislocations, which obstruct blood circulation and lead to bone tissue death. Diagnosis methods for AVN include imaging techniques, biopsies, computed tomography (CT) scans, positron emission tomography (PET), and X-rays. Treatment options range from medication and surgery to physical therapy, lifestyle modifications, and bone grafting. The condition is managed across various healthcare settings, including hospitals, specialty clinics, rehabilitation centers, ambulatory surgical centers, and home care environments.
The avascular necrosis market research report is one of a series of new reports from The Business Research Company that provides avascular necrosis market statistics, including avascular necrosis industry global market size, regional shares, competitors with an avascular necrosis market share, detailed avascular necrosis market segments, market trends and opportunities, and any further data you may need to thrive in the avascular necrosis industry. This avascular necrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The avascular necrosis market size has grown strongly in recent years. It will grow from $0.81 billion in 2024 to $0.89 billion in 2025 at a compound annual growth rate (CAGR) of 9.7%. The growth during the historic period can be attributed to several factors, including the increasing aging population, rising levels of alcohol consumption, expansion of sports medicine, growth in medical tourism, and advancements in precision medicine.
The avascular necrosis market size is expected to see strong growth in the next few years. It will grow to $1.27 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The anticipated growth during the forecast period can be credited to the increasing incidence of corticosteroid-induced osteonecrosis, a rising number of knee replacements and hip surgeries, a surge in drug approvals, a higher rate of road accidents, and a growing prevalence of bone injuries. Key trends expected in the forecast period include technological innovations, advancements in imaging technologies, AI-driven diagnostic solutions, 3D-printed surgical implants, regenerative orthobiologics, and cellular therapies.
The increasing number of knee and hip replacement surgeries is anticipated to drive the growth of the avascular necrosis market in the coming years. Knee and hip replacements are surgical procedures aimed at replacing damaged joints and alleviating pain in severe cases of avascular necrosis. This rise in surgical procedures is largely due to the growing incidence of osteoarthritis, a condition that leads to intense joint pain and impaired mobility, often necessitating surgical intervention to enhance quality of life. Avascular necrosis plays a significant role in creating the need for such surgeries, as it causes the death of bone tissue from reduced blood flow, which frequently results in joint collapse and deterioration. For example, in September 2023, Curvo Labs, Inc., a U.S.-based healthcare technology firm, reported that knee replacement procedures in the U.S. rose from 1,235,835 in 2021 to 1,299,084 in 2022. Thus, the rising number of knee and hip replacements is fueling the growth of the avascular necrosis market.
The increasing healthcare expenditure is projected to support the growth of the avascular necrosis market in the future. Healthcare expenditure refers to the total spending on medical services, treatments, and health-related products within a given population or healthcare system. This expenditure is rising due to the growing prevalence of chronic illnesses, which demand ongoing management, repeated hospital visits, and expensive medications. In the context of avascular necrosis, higher healthcare spending facilitates access to early diagnosis, advanced therapeutic options, and surgical interventions that aid in managing the condition and improving patient outcomes. For example, in April 2025, the American Medical Association, a U.S.-based organization representing physicians and medical students, reported that health spending in the U.S. rose by 7.5% in 2023 to $4.9 trillion, or $14,570 per person, up from a 4.6% increase in 2022. Hence, the rise in healthcare expenditure is contributing to the growth of the avascular necrosis market.
Leading companies in the avascular necrosis market are securing regulatory approvals to broaden their product offerings, improve treatment alternatives, and reinforce their market position. Regulatory approvals are official authorizations granted by health authorities, allowing a medical product or therapy to be marketed and used after demonstrating compliance with safety and efficacy standards. For example, in May 2022, Regrow Biosciences, a biotechnology company based in India, received approval from the United States Food and Drug Administration to initiate Phase II clinical trials in the U.S. for OSSGROW, an orphan drug intended for the treatment of osteonecrosis (avascular necrosis). OSSGROW is an innovative, patient-specific bone cell therapy developed by Regrow Biosciences for the curative treatment of early to moderate stages (up to Stage III) of avascular necrosis. The treatment involves collecting the patient's bone marrow, isolating mesenchymal stem cells, and culturing them in a specialized lab to generate osteoblasts-cells responsible for forming bone. OSSGROW is regarded as a natural, safe, and potentially long-term solution designed to replace conventional therapies and joint replacement surgeries that only alleviate symptoms.
Major players in the avascular necrosis market are Stryker Corporation, Massachusetts General Hospital, Zimmer Biomet Holdings Inc., Smith & Nephew plc, Stanford Health Care, Apollo Hospitals Enterprise Limited, Singapore General Hospital Pte Ltd., Fortis Healthcare Limited, Narayana Hrudayalaya Limited, Bumrungrad International Hospital Co. Ltd., Aster DM Healthcare Limited, Mount Elizabeth Hospital Pte Ltd., Gleneagles Hospital Pte Ltd., Shalby Limited, Texas Orthopedic Hospital LLC, Regrow Biosciences Pvt. Ltd., Maxcure Hospitals Limited, Medicover Hospitals Private Limited, Mesoblast Limited, Athersys Inc., Ginger Healthcare Private Limited.
North America was the largest region in the avascular necrosis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in avascular necrosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the avascular necrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The avascular necrosis market consists of revenues earned by entities by providing services such as radiology services, pharmacotherapy management services, long-term preventive treatment, and rehabilitation services. The market value includes the value of related goods sold by the service provider or included within the service offering. The avascular necrosis market also includes sales of products, including bone graft materials, orthopedic implants, C1 esterase inhibitors, and platelet-rich plasma kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Avascular Necrosis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on avascular necrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for avascular necrosis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The avascular necrosis market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Type: Trauma Related Avascular Necrosis; Non-Trauma Related Avascular Necrosis
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Avascular Necrosis Market Characteristics
3. Avascular Necrosis Market Trends And Strategies
4. Avascular Necrosis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Avascular Necrosis Growth Analysis And Strategic Analysis Framework
5.1. Global Avascular Necrosis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Avascular Necrosis Market Growth Rate Analysis
5.4. Global Avascular Necrosis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Avascular Necrosis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Avascular Necrosis Total Addressable Market (TAM)
6. Avascular Necrosis Market Segmentation
6.1. Global Avascular Necrosis Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Trauma Related Avascular Necrosis
Non-Trauma Related Avascular Necrosis
6.2. Global Avascular Necrosis Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Imaging
Biopsy
Computed Tomography Scan
Positron Emission Tomography
X-Ray
6.3. Global Avascular Necrosis Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Medications
Surgery
Physical Therapy
Lifestyle Changes
Bone Grafting
6.4. Global Avascular Necrosis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals
Specialty Clinics
Rehabilitation Centers
Ambulatory Surgical Centers
Home Care Settings
6.5. Global Avascular Necrosis Market, Sub-Segmentation Of Trauma Related Avascular Necrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fracture-Induced Avascular Necrosis
Dislocation-Induced Avascular Necrosis
Post-Surgical Avascular Necrosis
Crush Injury-Related Avascular Necrosis
Sports Injury-Associated Avascular Necrosis
6.6. Global Avascular Necrosis Market, Sub-Segmentation Of Non-Trauma Related Avascular Necrosis, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Steroid-Induced Avascular Necrosis
Alcohol-Induced Avascular Necrosis
Sickle Cell Disease-Associated Avascular Necrosis
Lupus-Related Avascular Necrosis
Radiation Therapy-Induced Avascular Necrosis
Idiopathic Avascular Necrosis
7. Avascular Necrosis Market Regional And Country Analysis
7.1. Global Avascular Necrosis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Avascular Necrosis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
